 Ocugen NASDAQ: OCGN stock was up nearly 15 today in premarket trading after the biotechnology company announced that Washington University has signed a licensing agreement with the company for its intranasal Covid-19 vaccine. However, after the market opened, it dropped down to only about 3 in the green. 